Organigram Global (OGI) Change in Receivables (2018 - 2021)
Organigram Global (OGI) posted quarterly Change in Receivables of -$5.7 million for Q2 2021, down 203.49% year-on-year from $5.5 million in Q2 2020, and down 228.22% on a QoQ basis from $4.4 million in Q1 2021.
Organigram Global (OGI) Change in Receivables (2018 - 2021) Analysis & Trends
Organigram Global (OGI) has reported Change in Receivables for 4 consecutive years, with -$5.7 million the latest figure, recorded in Q2 2021.
- Quarterly Change in Receivables fell 203.49% year-over-year to -$5.7 million in Q2 2021, while the trailing twelve-month figure through May 2021 was -$366952.7 (down 102.77% YoY) and the FY2022 annual result came in at -$18.9 million, down 298.8% from the prior year.
- Change in Receivables fell to -$5.7 million in Q2 2021 per OGI's latest filing, from $4.4 million in the prior quarter.
- Over the last five years, Change in Receivables for OGI reached as high as $13.1 million in Q1 2019 and fell as low as -$5.7 million in Q2 2021.
- A 4-year average of $3.7 million and a median of $3.3 million in 2020 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2020 — Change in Receivables sank 228.3% — and 2021, when it jumped 989.56%.
- Year by year, Change in Receivables stood at $11.1 million in 2018, then plunged by 90.53% to $1.0 million in 2019, then surged by 112.41% to $2.2 million in 2020, then tumbled by 354.71% to -$5.7 million in 2021.
- According to Business Quant data, Change in Receivables over the past three periods registered -$5.7 million, $4.4 million, and $2.2 million for Q2 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.04 Bn | 20.89 Bn | 648.10 Mn | -38.20 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.60 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.49 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | - |
| 10 | Organigram Global | 120.15 Mn | 153.23 Mn | 28.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2021 | -5.68 Mn |
| May 31, 2021 | -5.68 Mn |
| Feb 28, 2021 | 4.43 Mn |
| Feb 28, 2021 | 4.43 Mn |
| Nov 30, 2020 | 2.23 Mn |
| Nov 30, 2020 | 2.23 Mn |
| Aug 31, 2020 | -1.35 Mn |
| Aug 31, 2020 | -1.35 Mn |
| May 31, 2020 | 5.49 Mn |
| May 31, 2020 | 5.49 Mn |
| Feb 29, 2020 | -498,000.00 |
| Feb 29, 2020 | -498,000.00 |
| Aug 31, 2019 | 1.05 Mn |
| Aug 31, 2019 | 1.05 Mn |
| May 31, 2019 | 7.19 Mn |
| May 31, 2019 | 7.19 Mn |
| Feb 28, 2019 | 13.06 Mn |
| Feb 28, 2019 | 13.06 Mn |
| Nov 30, 2018 | 11.09 Mn |
| Nov 30, 2018 | 11.09 Mn |